{"id":20059,"date":"2025-08-26T13:15:03","date_gmt":"2025-08-26T13:15:03","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=20059"},"modified":"2025-08-26T13:15:03","modified_gmt":"2025-08-26T13:15:03","slug":"austria-and-germany-first-in-eu-to-launch-leqembi","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/","title":{"rendered":"\u30aa\u30fc\u30b9\u30c8\u30ea\u30a2\u3068\u30c9\u30a4\u30c4\u304cEU\u3067\u521d\u3081\u3066LEQEMBI\u3092\u767a\u58f2"},"content":{"rendered":"

\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u30fb\u30a4\u30f3\u30af\u306f\u3001\u6297\u30a2\u30df\u30ed\u30a4\u30c9\u03b2\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53LEQEMBI\uff08\u4e00\u822c\u540d\uff1alecanemab\uff09\u304c2025\u5e748\u670825\u65e5\u306b\u30aa\u30fc\u30b9\u30c8\u30ea\u30a2\u3067\u767a\u58f2\u3055\u308c\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30c9\u30a4\u30c4\u3067\u306f2025\u5e749\u67081\u65e5\u306b\u767a\u58f2\u4e88\u5b9a\u3067\u3059\u3002\u3053\u308c\u3089\u306f\u3001\u3053\u306e\u6cbb\u7642\u85ac\u306b\u3068\u3063\u3066\u6700\u521d\u306e\u6b27\u5dde\u9023\u5408\uff08EU\uff09\u5e02\u5834\u3068\u306a\u308a\u307e\u3059\u3002<\/p>

In April 2025, the European Commission approved LEQEMBI. It’s the first treatment to directly target a main cause of Alzheimer’s disease (AD). It’s for adults with early Alzheimer’s disease. This includes those with mild cognitive impairment or mild dementia. This applies to ApoE4 non-carriers or heterozygotes with confirmed amyloid pathology.<\/p>

\u30a8\u30fc\u30b6\u30a4\u306f\u533b\u7642\u5f53\u5c40\u3068\u5354\u529b\u3057\u3001\u30a2\u30af\u30bb\u30b9\u5236\u5fa1\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u73fe\u5728\u3001\u30aa\u30fc\u30b9\u30c8\u30ea\u30a2\u3068\u30c9\u30a4\u30c4\u3067\u5b9f\u65bd\u3055\u308c\u3066\u3044\u307e\u3059\u3002LEQEMBI\u306f\u30a2\u30df\u30ed\u30a4\u30c9\u6591\u3068\u539f\u7dda\u7dad\u3092\u6a19\u7684\u3068\u3059\u308b\u552f\u4e00\u306e\u6cbb\u7642\u85ac\u3067\u3059\u3002\u3053\u308c\u306f\u5f8c\u306e\u30bf\u30a6\u75c5\u614b\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002
\n\u30af\u30e9\u30ea\u30c6\u30a3AD\u8a66\u9a13\u3067\u306f\u3001\u6cbb\u7642\u306b\u3088\u308a\u30d7\u30e9\u30bb\u30dc\u3068\u6bd4\u8f03\u3057\u306618\u30f5\u6708\u5f8c\u306e\u81e8\u5e8a\u7684\u4f4e\u4e0b\u304c31%\u6e1b\u5c11\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u5bfe\u8c61\u7fa4\u306b\u304a\u3051\u308bCDR-SB\u30b9\u30b1\u30fc\u30eb\u3067\u6e2c\u5b9a\u3055\u308c\u307e\u3057\u305f\u3002\u4e3b\u306a\u6709\u5bb3\u4e8b\u8c61\u306f\u3001\u8f38\u6db2\u95a2\u9023\u53cd\u5fdc\uff0826%\uff09\u3001ARIA-H\uff0813%\uff09\u3001\u982d\u75db\uff0811%\uff09\u3001ARIA-E\uff089%\uff09\u3002<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a JDSC\u3001\u533b\u85ac\u54c1\u88fd\u9020\u306e\u305f\u3081\u306e\u30b9\u30de\u30fc\u30c8\u30d5\u30a1\u30af\u30c8\u30ea\u30fc\u3092\u7acb\u3061\u4e0a\u3052<\/a><\/h4>

Eisai<\/a> \u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u958b\u767a\u30fb\u898f\u5236\u696d\u52d9\u3092\u7d71\u62ec\u3057\u3066\u3044\u307e\u3059\u3002\u30a8\u30fc\u30b6\u30a4\u3068 Biogen<\/a> \u3082\u5171\u540c\u8ca9\u4fc3\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u5317\u6b27\u8af8\u56fd\u3092\u9664\u304fEU\u8af8\u56fd\u3067\u306f\u3001\u30a8\u30fc\u30b6\u30a4\u304c\u8ca9\u58f2\u627f\u8a8d\u8005\u304a\u3088\u3073\u8ca9\u58f2\u5143\u3067\u3059\u3002<\/p>","protected":false},"excerpt":{"rendered":"

Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid beta monoclonal antibody, launched in Austria on August 25, 2025. It will launch in Germany on September 1, 2025. These mark the first European Union (EU) markets for the therapy.In April 2025, the European Commission approved LEQEMBI. It’s the first treatment to directly target a main cause of Alzheimer’s disease (AD). It’s for adults with early Alzheimer’s disease. This includes those with mild cognitive impairment or mild dementia. This applies to ApoE4 non-carriers or heterozygotes with confirmed amyloid pathology.Eisai has teamed up with healthcare authorities to create a controlled access program. This program is now active in Austria […]<\/p>\n","protected":false},"author":7,"featured_media":20060,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,207,237,182],"tags":[872,7394,1715,7393,424],"ppma_author":[572],"class_list":["post-20059","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-international","category-news","category-pharma","tag-alzheimer-disease","tag-biogen","tag-eisai","tag-leqembi","tag-pharma"],"yoast_head":"\nLEQEMBI to Launch First in Austria and Germany<\/title>\n<meta name=\"description\" content=\"Eisai and Biogen announced the launch of LEQEMBI in Austria with Germany to follow on September 1, marking its first EU rollout.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LEQEMBI to Launch First in Austria and Germany\" \/>\n<meta property=\"og:description\" content=\"Eisai and Biogen announced the launch of LEQEMBI in Austria with Germany to follow on September 1, marking its first EU rollout.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-26T13:15:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Austria-and-Germany-to-become-the-first-markets-in-the-European-Union-EU-to-launch-LEQEMBIR-lecanemab.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LEQEMBI\u304c\u30aa\u30fc\u30b9\u30c8\u30ea\u30a2\u3068\u30c9\u30a4\u30c4\u3067\u5148\u884c\u767a\u58f2","description":"\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u306f\u3001LEQEMBI\u3092\u30aa\u30fc\u30b9\u30c8\u30ea\u30a2\u3067\u767a\u58f2\u3057\u30019\u67081\u65e5\u306b\u306f\u30c9\u30a4\u30c4\u3067\u3082\u767a\u58f2\u3059\u308b\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/","og_locale":"ja_JP","og_type":"article","og_title":"LEQEMBI to Launch First in Austria and Germany","og_description":"Eisai and Biogen announced the launch of LEQEMBI in Austria with Germany to follow on September 1, marking its first EU rollout.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/","og_site_name":"itbusinesstoday","article_published_time":"2025-08-26T13:15:03+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Austria-and-Germany-to-become-the-first-markets-in-the-European-Union-EU-to-launch-LEQEMBIR-lecanemab.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Austria and Germany First in EU to Launch LEQEMBI","datePublished":"2025-08-26T13:15:03+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/"},"wordCount":215,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Austria-and-Germany-to-become-the-first-markets-in-the-European-Union-EU-to-launch-LEQEMBIR-lecanemab.webp","keywords":["Alzheimer disease","Biogen","Eisai","LEQEMBI","Pharma"],"articleSection":["Health Tech","International","News","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/","name":"LEQEMBI\u304c\u30aa\u30fc\u30b9\u30c8\u30ea\u30a2\u3068\u30c9\u30a4\u30c4\u3067\u5148\u884c\u767a\u58f2","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Austria-and-Germany-to-become-the-first-markets-in-the-European-Union-EU-to-launch-LEQEMBIR-lecanemab.webp","datePublished":"2025-08-26T13:15:03+00:00","description":"\u30a8\u30fc\u30b6\u30a4\u3068\u30d0\u30a4\u30aa\u30b8\u30a7\u30f3\u306f\u3001LEQEMBI\u3092\u30aa\u30fc\u30b9\u30c8\u30ea\u30a2\u3067\u767a\u58f2\u3057\u30019\u67081\u65e5\u306b\u306f\u30c9\u30a4\u30c4\u3067\u3082\u767a\u58f2\u3059\u308b\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Austria-and-Germany-to-become-the-first-markets-in-the-European-Union-EU-to-launch-LEQEMBIR-lecanemab.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/08\/Austria-and-Germany-to-become-the-first-markets-in-the-European-Union-EU-to-launch-LEQEMBIR-lecanemab.webp","width":1200,"height":800,"caption":"Eisai"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/austria-and-germany-first-in-eu-to-launch-leqembi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Austria and Germany First in EU to Launch LEQEMBI"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=20059"}],"version-history":[{"count":3,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20059\/revisions"}],"predecessor-version":[{"id":20065,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20059\/revisions\/20065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/20060"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=20059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=20059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=20059"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=20059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}